Parkinson’s disease is characterized by synucleinopathy-associated neurodegeneration.Previous studies have shown that glucagon-like peptide-1(GLP-1)has beneficial effects in a mouse model of Parkinson’s disease indu...Parkinson’s disease is characterized by synucleinopathy-associated neurodegeneration.Previous studies have shown that glucagon-like peptide-1(GLP-1)has beneficial effects in a mouse model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.However,the effect of GLP-1 on intrinsic synuclein malfunction remains unclear.In this study,we investigated the effect of Lactococcus lactis MG1363-pMG36e-GLP-1 on parkinsonism in SncaA53T transgenic mice and explored the underlying mechanisms.Our data showed that Lactococcus lactis MG1363-pMG36e-GLP-1 inhibited dopaminergic neuronal death,reduced pathological aggregation ofα-synuclein,and decreased movement disorders in SncaA53T transgenic mice.Furthermore,Lactococcus lactis MG1363-pMG36e-GLP-1 downregulated lipopolysaccharide-related inflammation,reduced cerebral activation of microglia and astrocytes,and promoted cell survival via the GLP-1 receptor/PI3K/Akt pathway in the substantia nigra.Additionally,Lactococcus lactis MG1363-pMG36e-GLP-1 decreased serum levels of pro-inflammatory molecules including lipopolysaccharide,lipopolysaccharide binding protein,interleukin-1β,and interleukin-6.Gut histopathology and western blotting further revealed that Lactococcus lactis MG1363-pMG36e-GLP-1 increased the expression of gut integrity-related proteins and reduced lipopolysaccharide-related inflammation by reversing gut dysbiosis in SncaA53T transgenic mice.Our findings showed that the beneficial effect of Lactococcus lactis MG1363-pMG36e-GLP-1 on parkinsonism traits in SncaA53T transgenic mice is mediated by microglial polarization and the reversal of dysbiosis.Collectively,our findings suggest that Lactococcus lactis MG1363-pMG36e-GLP-1 is a promising therapeutic agent for the treatment of Parkinson’s disease.展开更多
[目的]明确36%烯肟·氟环唑SC对玉米小斑病的防治效果。[方法]以17%唑醚·氟环唑SC和30%肟菌·戊唑醇SC为对照药剂,在山东省潍坊市寒亭区高里街道河南村玉米田进行田间小区试验。[结果]36%烯肟·氟环唑SC81、108 g a.i....[目的]明确36%烯肟·氟环唑SC对玉米小斑病的防治效果。[方法]以17%唑醚·氟环唑SC和30%肟菌·戊唑醇SC为对照药剂,在山东省潍坊市寒亭区高里街道河南村玉米田进行田间小区试验。[结果]36%烯肟·氟环唑SC81、108 g a.i./hm^(2)处理对玉米小斑病效果优于对照药剂17%唑醚·氟环唑SC和30%肟菌·戊唑醇SC,54 g a.i./hm^(2)的36%烯肟·氟环唑SC处理对玉米小斑病效果与对照药剂无显著性差异。[结论]使用36%烯肟·氟环唑SC54~108 g a.i./hm^(2)在玉米小斑病发病前或发病初期茎叶均匀喷雾,间隔7~10 d再施用1次,可有效防治玉米小斑病。展开更多
基金supported by grants from the Jiangxi Provincial Natural Science Foundation,No.20242BAB26134(to XF)the National Natural Science Foundation of China,Nos.82060638(to TC),82060222(to XF),82460237(to XF)+1 种基金the Major Disciplines of Academic and Technical Leaders Project of Jiangxi Province,Nos.20194BCJ22032(to TC),20213BCJL22049(to XF)Science and Technology Plan of Jiangxi Health Planning Committee,No.202210390(to XF).
文摘Parkinson’s disease is characterized by synucleinopathy-associated neurodegeneration.Previous studies have shown that glucagon-like peptide-1(GLP-1)has beneficial effects in a mouse model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.However,the effect of GLP-1 on intrinsic synuclein malfunction remains unclear.In this study,we investigated the effect of Lactococcus lactis MG1363-pMG36e-GLP-1 on parkinsonism in SncaA53T transgenic mice and explored the underlying mechanisms.Our data showed that Lactococcus lactis MG1363-pMG36e-GLP-1 inhibited dopaminergic neuronal death,reduced pathological aggregation ofα-synuclein,and decreased movement disorders in SncaA53T transgenic mice.Furthermore,Lactococcus lactis MG1363-pMG36e-GLP-1 downregulated lipopolysaccharide-related inflammation,reduced cerebral activation of microglia and astrocytes,and promoted cell survival via the GLP-1 receptor/PI3K/Akt pathway in the substantia nigra.Additionally,Lactococcus lactis MG1363-pMG36e-GLP-1 decreased serum levels of pro-inflammatory molecules including lipopolysaccharide,lipopolysaccharide binding protein,interleukin-1β,and interleukin-6.Gut histopathology and western blotting further revealed that Lactococcus lactis MG1363-pMG36e-GLP-1 increased the expression of gut integrity-related proteins and reduced lipopolysaccharide-related inflammation by reversing gut dysbiosis in SncaA53T transgenic mice.Our findings showed that the beneficial effect of Lactococcus lactis MG1363-pMG36e-GLP-1 on parkinsonism traits in SncaA53T transgenic mice is mediated by microglial polarization and the reversal of dysbiosis.Collectively,our findings suggest that Lactococcus lactis MG1363-pMG36e-GLP-1 is a promising therapeutic agent for the treatment of Parkinson’s disease.
文摘[目的]明确36%烯肟·氟环唑SC对玉米小斑病的防治效果。[方法]以17%唑醚·氟环唑SC和30%肟菌·戊唑醇SC为对照药剂,在山东省潍坊市寒亭区高里街道河南村玉米田进行田间小区试验。[结果]36%烯肟·氟环唑SC81、108 g a.i./hm^(2)处理对玉米小斑病效果优于对照药剂17%唑醚·氟环唑SC和30%肟菌·戊唑醇SC,54 g a.i./hm^(2)的36%烯肟·氟环唑SC处理对玉米小斑病效果与对照药剂无显著性差异。[结论]使用36%烯肟·氟环唑SC54~108 g a.i./hm^(2)在玉米小斑病发病前或发病初期茎叶均匀喷雾,间隔7~10 d再施用1次,可有效防治玉米小斑病。
